PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

about

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

Item

http://www.wikidata.org/entity/Q24239870

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@ast

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en-gb

PRO 140

@nl

type

Item

label

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@ast

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en-gb

PRO 140

@nl

prefLabel

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@ast

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en-gb

PRO 140

@nl

P1476

PRO 140 (a CCR5 monoclonal antibody) for treatment in people with HIV infection

@en

P2093

KeHu Yang

http://www.w3.org/2001/XMLSchema#string

Lun Li

http://www.w3.org/2001/XMLSchema#string

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

TianTian Sun

http://www.w3.org/2001/XMLSchema#string

Wen Qin Jia

http://www.w3.org/2001/XMLSchema#string

P2860

Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1

Access denied? The status of co-receptor inhibition to counter HIV entry

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.

Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.

Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)

P31

scholarly article

P356

10.1002/14651858.CD008439

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime